Against the accelerating aging of the population and profound changes in lifestyles, metabolic comorbidities have become a major public health issue endangering national health, with their persistently rising prevalence and trend toward younger age groups raising significant concerns. To further advance the concept of population-wide health management, break through traditional specialty barriers, and establish a new multidisciplinary collaborative model for comorbidity prevention and control, the Chengdu High-Tech Medical Association has decided to hold the 13th session of the symposium, "Dyslipidemia, Hyperglycemia, and Hypertension from a Population-Wide Perspective: Management and Challenges of Comorbidities," online on August 24, 2025.

The conference focused on cutting-edge scientific breakthroughs and innovations in clinical practice, delving into bottleneck issues and solutions in early screening, precise intervention, and long-term management of the "three highs" comorbidities, with special attention given to the health management needs of vulnerable populations. By providing a high-level academic exchange platform, the event not only facilitated the碰撞融合 (collision and integration) of knowledge and experience among experts and scholars but also offered critical support for optimizing and upgrading the chronic disease prevention and control system. It played an active role in enhancing population-wide health management standards and advancing the Healthy China initiative.